Horizon Therapeutics Public Ltd Co Quarterly Depreciation in USD from Q2 2011 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Horizon Therapeutics Public Ltd Co quarterly/annual Depreciation history and growth rate from Q2 2011 to Q2 2023.
  • Horizon Therapeutics Public Ltd Co Depreciation for the quarter ending June 30, 2023 was $6.7M, a 9.84% increase year-over-year.
  • Horizon Therapeutics Public Ltd Co Depreciation for the twelve months ending June 30, 2023 was $24.8M, a 14.5% increase year-over-year.
  • Horizon Therapeutics Public Ltd Co annual Depreciation for 2022 was $23.9M, a 36.6% increase from 2021.
  • Horizon Therapeutics Public Ltd Co annual Depreciation for 2021 was $17.5M, a 28% decline from 2020.
  • Horizon Therapeutics Public Ltd Co annual Depreciation for 2020 was $24.3M, a 261% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $24.8M $6.7M +$600K +9.84% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $24.2M $6.2M +$300K +5.09% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $23.9M $5.77M +$225K +4.06% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $23.7M $6.13M +$2.02M +49.1% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $21.7M $6.1M +$2.71M +79.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $18.9M $5.9M +$1.45M +32.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $17.5M $5.55M +$474K +9.35% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $17M $4.11M -$1.05M -20.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $18.1M $3.39M -$3.51M -50.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $21.6M $4.45M -$2.71M -37.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $24.3M $5.07M +$2.91M +135% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $21.4M $5.16M +$3.5M +211% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $17.9M $6.91M +$5.46M +379% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $12.4M $7.17M +$5.69M +386% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $6.73M $2.16M +$659K +43.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $6.07M $1.66M +$135K +8.86% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $5.94M $1.44M -$108K -6.96% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $6.05M $1.47M -$79K -5.09% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $6.13M $1.5M -$100K -6.25% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $6.23M $1.52M +$47K +3.18% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $6.18M $1.55M -$204K -11.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $6.38M $1.55M -$248K -13.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $6.63M $1.6M -$62K -3.73% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $6.69M $1.48M +$276K +23% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $6.42M $1.76M +$655K +59.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $5.76M $1.8M +$800K +80% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $4.96M $1.66M -$838K -33.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $5.8M $1.2M -$400K -25% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $6.2M $1.1M +$500K +83.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $5.7M $1M +$300K +42.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $5.4M $2.5M +$2M +400% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $3.4M $1.6M +$1.2M +300% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $2.2M $600K +$200K +50% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $2M $700K +$300K +75% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $1.7M $500K +$161K +47.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $1.54M $400K +$98K +32.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $1.44M $400K +$100K +33.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $1.34M $400K +$141K +54.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $1.2M $339K +$98K +40.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $1.1M $302K +$135K +80.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $967K $300K +$92K +44.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $875K $259K +$75K +40.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $800K $241K Oct 1, 2012 Dec 31, 2012 10-K/A 2015-03-02
Q3 2012 $167K +$69K +70.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $208K +$107K +106% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $184K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q3 2011 $98K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $101K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.